MX2007004259A - Uso de compuestos organicos. - Google Patents
Uso de compuestos organicos.Info
- Publication number
- MX2007004259A MX2007004259A MX2007004259A MX2007004259A MX2007004259A MX 2007004259 A MX2007004259 A MX 2007004259A MX 2007004259 A MX2007004259 A MX 2007004259A MX 2007004259 A MX2007004259 A MX 2007004259A MX 2007004259 A MX2007004259 A MX 2007004259A
- Authority
- MX
- Mexico
- Prior art keywords
- organic compounds
- calcitonin
- relates
- calictonin
- salmon
- Prior art date
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 102000055006 Calcitonin Human genes 0.000 abstract 2
- 108060001064 Calcitonin Proteins 0.000 abstract 2
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 2
- 229960004015 calcitonin Drugs 0.000 abstract 2
- 241000316144 Macrodon ancylodon Species 0.000 abstract 1
- 230000008468 bone growth Effects 0.000 abstract 1
- 230000011164 ossification Effects 0.000 abstract 1
- -1 salmon calictonin Chemical compound 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/225—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0422644.5A GB0422644D0 (en) | 2004-10-12 | 2004-10-12 | Organic compounds |
| PCT/EP2005/010892 WO2006040114A1 (en) | 2004-10-12 | 2005-10-10 | Use of organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007004259A true MX2007004259A (es) | 2007-05-11 |
Family
ID=33443790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007004259A MX2007004259A (es) | 2004-10-12 | 2005-10-10 | Uso de compuestos organicos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090048157A1 (OSRAM) |
| EP (1) | EP1802328A1 (OSRAM) |
| JP (1) | JP2008515947A (OSRAM) |
| KR (1) | KR20070061864A (OSRAM) |
| CN (1) | CN101035556A (OSRAM) |
| AU (1) | AU2005293802A1 (OSRAM) |
| BR (1) | BRPI0516872A (OSRAM) |
| CA (1) | CA2580766A1 (OSRAM) |
| GB (1) | GB0422644D0 (OSRAM) |
| MX (1) | MX2007004259A (OSRAM) |
| RU (1) | RU2007117492A (OSRAM) |
| TW (1) | TW200628168A (OSRAM) |
| WO (1) | WO2006040114A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101309674A (zh) | 2005-11-17 | 2008-11-19 | 诺瓦提斯公司 | 药物组合物 |
| CN102292346B (zh) | 2009-01-22 | 2015-12-02 | 关键生物科学有限公司 | 肥胖的治疗 |
| MX351092B (es) * | 2011-11-02 | 2017-10-02 | Keybioscience Ag | Analogos peptidicos para tratar enfermedades y trastornos. |
| US9533022B2 (en) | 2011-11-02 | 2017-01-03 | KeyBioscience A/S | Peptide analogs for treating diseases and disorders |
| EP3095484B1 (en) * | 2011-11-02 | 2018-05-02 | KeyBioscience AG | Calcitonin mimetics for treating diseases and disorders |
| CN107345965A (zh) * | 2016-05-04 | 2017-11-14 | 广州优迪生物科技有限公司 | 一种同时检测N-MID和β-CTX的双标记时间分辨荧光免疫分析方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629020A (en) * | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| GB9108634D0 (en) * | 1991-04-23 | 1991-06-12 | Ciba Geigy | Pharmaceutical compositions |
| DE726075T1 (de) * | 1995-02-08 | 1996-12-12 | Therapicon Srl | Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung |
| IT1282374B1 (it) * | 1996-01-31 | 1998-03-20 | Therapicon Srl | Composizioni farmaceutiche parenterali a base di calcitonine sintetiche a ph controllato con basso indice di dolorosita' |
| NZ534409A (en) * | 1999-04-05 | 2006-03-31 | Emisphere Tech Inc | Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| US20040110170A1 (en) * | 2002-05-18 | 2004-06-10 | The Regents Of The University Of California | Cloning and characterization of calcitonin gene related peptide receptors |
| TW200411053A (en) * | 2002-12-30 | 2004-07-01 | Ind Tech Res Inst | Nucleic acid encoding recombinant salmon calcitionin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith |
-
2004
- 2004-10-12 GB GBGB0422644.5A patent/GB0422644D0/en not_active Ceased
-
2005
- 2005-10-10 MX MX2007004259A patent/MX2007004259A/es not_active Application Discontinuation
- 2005-10-10 KR KR1020077008224A patent/KR20070061864A/ko not_active Withdrawn
- 2005-10-10 CN CNA2005800339490A patent/CN101035556A/zh active Pending
- 2005-10-10 RU RU2007117492/14A patent/RU2007117492A/ru not_active Application Discontinuation
- 2005-10-10 WO PCT/EP2005/010892 patent/WO2006040114A1/en not_active Ceased
- 2005-10-10 US US11/577,127 patent/US20090048157A1/en not_active Abandoned
- 2005-10-10 EP EP05795076A patent/EP1802328A1/en not_active Withdrawn
- 2005-10-10 JP JP2007536066A patent/JP2008515947A/ja active Pending
- 2005-10-10 AU AU2005293802A patent/AU2005293802A1/en not_active Abandoned
- 2005-10-10 BR BRPI0516872-4A patent/BRPI0516872A/pt not_active IP Right Cessation
- 2005-10-10 CA CA002580766A patent/CA2580766A1/en not_active Abandoned
- 2005-10-11 TW TW094135420A patent/TW200628168A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006040114A1 (en) | 2006-04-20 |
| JP2008515947A (ja) | 2008-05-15 |
| TW200628168A (en) | 2006-08-16 |
| CN101035556A (zh) | 2007-09-12 |
| GB0422644D0 (en) | 2004-11-10 |
| CA2580766A1 (en) | 2006-04-20 |
| RU2007117492A (ru) | 2008-11-20 |
| AU2005293802A1 (en) | 2006-04-20 |
| BRPI0516872A (pt) | 2008-09-23 |
| KR20070061864A (ko) | 2007-06-14 |
| EP1802328A1 (en) | 2007-07-04 |
| US20090048157A1 (en) | 2009-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009000385A (es) | Acil-anilidas sustituidas y metodos de uso de las mismas. | |
| MX368173B (es) | Una composición farmacéutica que comprende una proteína de fusión actriia-fc expresada de células cho. | |
| SG135192A1 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| TW200626068A (en) | Active compounds for seed treatment | |
| ATE395871T1 (de) | Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen | |
| MX2009001962A (es) | Acilanilidas substituidas y metodos de uso de las mismas. | |
| ITRM20050265A1 (it) | Protesi modulare perfezionata per osteosintesi, in particolare per l'osteosintesi dell'omero. | |
| DE602005021970D1 (de) | Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen | |
| BRPI0508700A (pt) | uso de sns-595, composição farmacêutica, e, pó liofilizado | |
| SG151309A1 (en) | Novel use of peptide compounds for treating pain in painful diabetic neuropathy | |
| EP1686986A4 (en) | CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT | |
| GB0410399D0 (en) | The treatment of respiratory disease | |
| DE502005010499D1 (de) | Implantat zur Behandlung von Fettsucht | |
| IL178815A0 (en) | The treatment of respiratory disease | |
| DE602005009216D1 (de) | Zusammensetzung zur behandlung von saatgut | |
| IL178827A0 (en) | Use of reboxetine for the treatment of pain | |
| TW200628168A (en) | Use of organic compounds | |
| MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. | |
| ZA200704926B (en) | Modified human growth hormone | |
| UA87117C2 (ru) | Применение пептидных соединений для лечения центральной невропатической боли | |
| TW200738244A (en) | 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof | |
| GB0424085D0 (en) | Well treatment | |
| IL180709A0 (en) | Treatment of tumours | |
| TW200608986A (en) | Bioprotective agent | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |